A groundbreaking study involving over 18,000 individuals has shed light on the genetic advantages that “SuperAgers” possess, making them remarkably resilient to dementia in old age. These exceptional individuals, aged 80 and above, not only have a lower likelihood of carrying a gene variant associated with increased risk of Alzheimer’s disease but are also more likely to carry a gene variant linked to lower risk.
Neuropsychologist Leslie Gaynor of Vanderbilt University Medical Center in the US described this finding as the most striking result of the study. While genetics are not the sole determining factor, the study indicates that exceptional memory in advanced age may be partly attributed to the genetic makeup of SuperAgers.
SuperAgers are characterized by exceptional memory abilities that rival those of individuals decades younger. Moreover, they demonstrate a significantly lower risk of developing dementia compared to the general population. Researchers are keen to explore the mechanisms behind this phenomenon, as it could provide valuable insights into dementia and potential strategies for prevention and treatment.
The study focused on the Apolipoprotein E (APOE) gene, with the ε4 variant being the strongest genetic risk factor for Alzheimer’s disease. Conversely, the ε2 variant is associated with a reduced risk of the condition. Imaging studies have revealed structural differences in the brains of SuperAgers, suggesting a level of resistance to the amyloid plaques linked to Alzheimer’s.
Gaynor and her team, including statistical genetic analyst Alaina Durant, analyzed data from eight large aging studies in the US, encompassing cognitive performance tests and genetic information from participants. SuperAgers were defined as individuals aged 80 and above whose cognitive abilities surpassed those of cognitively normal individuals aged 50-64.
The results showed that SuperAgers were significantly less likely to carry the APOE-ε4 variant compared to individuals with Alzheimer’s disease. Additionally, they were more likely to carry the protective APOE-ε2 allele. These findings suggest that SuperAgers possess unique genetic characteristics that confer resilience against Alzheimer’s disease.
The study, published in Alzheimer’s & Dementia, marks a significant step in understanding the genetic underpinnings of exceptional memory and cognitive function in old age. Further research is needed to explore how these genetic variants influence the development of Alzheimer’s disease and the SuperAger phenotype.
Overall, this study underscores the importance of genetics in shaping cognitive health in old age and highlights the potential of SuperAgers as a model for studying resilience to Alzheimer’s disease. As interest in SuperAgers continues to grow, further investigations into the genetic factors contributing to their exceptional cognitive abilities are warranted.
